CTLA4 and neoplasm: In the tumor microvironment, tumor cells may inhibit the T cell responses by secret the immunosuppressive proteins that bind with the CTLA‐4 and PD‐1, shows to be a central target of immunosuppression in the therapeutic antitumor immunity.92